EA201990551A1 - Антибиотические соединения - Google Patents

Антибиотические соединения

Info

Publication number
EA201990551A1
EA201990551A1 EA201990551A EA201990551A EA201990551A1 EA 201990551 A1 EA201990551 A1 EA 201990551A1 EA 201990551 A EA201990551 A EA 201990551A EA 201990551 A EA201990551 A EA 201990551A EA 201990551 A1 EA201990551 A1 EA 201990551A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
antibiotic compounds
gram
infection
treatment
Prior art date
Application number
EA201990551A
Other languages
English (en)
Inventor
Др Пол Мео
Др. Наваз Кхан
Original Assignee
Дискува Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дискува Лтд. filed Critical Дискува Лтд.
Publication of EA201990551A1 publication Critical patent/EA201990551A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к антибиотическим соединениям формулы (I), к композициям, содержащим данные соединения, и способам лечения бактериальных заболеваний и инфекций. Соединения находят применение в лечении инфекции и заболевания, вызванного грамположительными и/или грамотрицательными бактериями, и, в частности, в лечении инфекции и заболевания, вызванного Neisseria gonorrhoeae.
EA201990551A 2016-08-22 2017-08-22 Антибиотические соединения EA201990551A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1614314.1A GB201614314D0 (en) 2016-08-22 2016-08-22 Antibiotic compounds
PCT/GB2017/052478 WO2018037223A1 (en) 2016-08-22 2017-08-22 Antibiotic compounds

Publications (1)

Publication Number Publication Date
EA201990551A1 true EA201990551A1 (ru) 2019-12-30

Family

ID=57045563

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990551A EA201990551A1 (ru) 2016-08-22 2017-08-22 Антибиотические соединения

Country Status (15)

Country Link
US (1) US20190194179A1 (ru)
EP (1) EP3500567A1 (ru)
JP (1) JP2019528291A (ru)
KR (1) KR20190046894A (ru)
CN (1) CN109923111A (ru)
AU (1) AU2017316742A1 (ru)
BR (1) BR112019003427A2 (ru)
CA (1) CA3034000A1 (ru)
CO (1) CO2019002624A2 (ru)
EA (1) EA201990551A1 (ru)
GB (1) GB201614314D0 (ru)
MX (1) MX2019001978A (ru)
PH (1) PH12019500360A1 (ru)
SG (1) SG11201901374WA (ru)
WO (1) WO2018037223A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI820232B (zh) 2018-10-11 2023-11-01 德商拜耳廠股份有限公司 用於製備咪唑衍生物之方法
EP3636645A1 (de) 2018-10-11 2020-04-15 Bayer Aktiengesellschaft Verfahren zur herstellung schwefel-substituierter pyridinderivate
BR112021014539A2 (pt) 2019-01-24 2021-10-13 Daiichi Sankyo Company, Limited Composto, ativador sirt6, composição farmacêutica, método para tratar e/ou prevenir uma doença inflamatória periférica e uso do composto
JP2022521339A (ja) * 2019-02-22 2022-04-06 アニフェラ・リミテッド グラム陽性菌に対して向上された抗菌活性を提供する組成物およびその使用
EP3952990A1 (en) * 2019-04-12 2022-02-16 Mitobridge, Inc. Hmox1 inducers
CN111808093B (zh) * 2019-04-12 2023-05-16 中国医学科学院医药生物技术研究所 一种新德里金属-β-内酰胺酶-1抑制剂
CN113185475A (zh) * 2021-04-29 2021-07-30 江苏永凯化学有限公司 一种高效低污染的精恶唑禾草灵生产工艺
WO2023234970A1 (en) * 2022-06-01 2023-12-07 KUDA Therapeutics, Inc. Imidazopyridine and oxazolopyridine derivatives and analogs thereof, methods of preparation thereof, methods of hif-1/2a pathway inhibition, and induction of ferroptosis
CN117003710A (zh) * 2023-07-19 2023-11-07 镇江先锋植保科技有限公司 一种2-巯基-6-氯苯并恶唑的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8604217B2 (en) * 2009-11-12 2013-12-10 Selvita S.A. Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
JP5786402B2 (ja) * 2011-03-29 2015-09-30 コニカミノルタ株式会社 光学フィルム、及びそれを用いた偏光板、液晶表示装置
WO2016039939A1 (en) * 2014-09-09 2016-03-17 Ptc Therapeutics, Inc. Bicyclic and tricyclic substituted 2-pyridinone antibacterial compounds

Also Published As

Publication number Publication date
CN109923111A (zh) 2019-06-21
SG11201901374WA (en) 2019-03-28
EP3500567A1 (en) 2019-06-26
BR112019003427A2 (pt) 2019-05-21
CO2019002624A2 (es) 2019-05-31
WO2018037223A1 (en) 2018-03-01
US20190194179A1 (en) 2019-06-27
AU2017316742A1 (en) 2019-04-11
GB201614314D0 (en) 2016-10-05
JP2019528291A (ja) 2019-10-10
PH12019500360A1 (en) 2019-11-11
MX2019001978A (es) 2019-08-01
CA3034000A1 (en) 2018-03-01
KR20190046894A (ko) 2019-05-07

Similar Documents

Publication Publication Date Title
EA201990551A1 (ru) Антибиотические соединения
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
EA202091118A1 (ru) Антибактериальные соединения
PH12017501019B1 (en) Isoxazole hydromaxamic acid compounds as lpxc inhibitors
NZ724798A (en) Polymyxin derivatives as antimicrobial compounds
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
NZ593111A (en) Antibacterial compounds
WO2018208987A3 (en) Antibacterial compounds
MX2021003084A (es) Compuestos antibacterianos.
MX2017009094A (es) Derivado de polimixina y usos del mismo.
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
MX2017012073A (es) Compuestos de minociclina para biodefensas.
WO2017218922A3 (en) Compositions and methods for the treatment of bacterial infections
BR112019024549A2 (pt) compostos derivados de glicopeptídeo e usos dos mesmos
EA201992370A1 (ru) Соединения и способы для лечения бактериальных инфекций
PH12016501532A1 (en) Antibacterial combinations comprising polymyxin
EA201590331A1 (ru) Новые антибактериальные соединения
PH12021551058A1 (en) Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof
MX2017012539A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
NZ737820A (en) Mannose derivatives for treating bacterial infections
EA201892278A1 (ru) Анбитактериальные биароматические производные с оксетан-3-илокси замещением
EA202190732A1 (ru) Антибактериальные соединения
EA202191343A1 (ru) Антибиотические соединения, способы их получения, фармацевтические композиции, содержащие их, и их применение
JO3477B1 (ar) مركبات أحادي باكتام عضوية لعلاج العدوى البكتيرية